Intervention not reported
Complete remission ( · patients with primary nephrotic syndrome
The intervention showed no clear difference in complete remission ( (low certainty).
1 finding from 1 review
Intervention not reported
Partial remission ( · patients with primary nephrotic syndrome
The intervention showed no clear difference in partial remission ( (low certainty).
1 finding from 1 review
Intervention not reported
Complete or partial remission ( · patients with primary nephrotic syndrome
The intervention showed no clear difference in complete or partial remission ( (low certainty).
1 finding from 1 review
ESKD · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)
Rheum officinale showed no clear difference in incidence of ESKD Analysis method, calculated by regression… compared with no treatment (low certainty).
1 finding from 1 review
Full time working capacity Unclear quality of life scale · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)
Rheum officinale showed no clear difference in full time working capacity Unclear quality of life scale compared with captopril (low certainty).
1 finding from 1 review
Part‐time working capacity Unclear quality of life scale · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)
Rheum officinale showed no clear difference in part‐time working capacity Unclear quality of life scale compared with captopril (low certainty).
1 finding from 1 review